3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
182
Ovarian Neoplasms
92
Carcinoma, Ovarian Epithelial
46
Fallopian Tube Neoplasms
35
Endometrial Neoplasms
29
Peritoneal Neoplasms
23
Stomach Neoplasms
18
Colorectal Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Neoplasms
11
Vulvar Neoplasms
9
Recurrence
9
Lung Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Pancreatic Neoplasms
7
Locally Advanced Cervical Cancer
7
Brenner Tumor
7
Uterine Neoplasms
6
Testicular Neoplasms
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Neoplasm Metastasis
6
Carcinoma
6
Urinary Bladder Neoplasms
5
Sarcoma
5
Colonic Neoplasms
5
Breast Neoplasms
5
Vaginal Neoplasms
4
Triple Negative Breast Neoplasms
4
Teratoma
4
Small Cell Lung Carcinoma
4
Interventions
Surveys and Questionnaires
2
Standard of Care
2
Drug Therapy
2
Brachytherapy
2
genexol-PM
1
gadobutrol
1
fosaprepitant
1
Therapeutics
1
Surgical Procedures, Operative
1
Sex
1
Radiotherapy, Intensity-Modulated
1
Psychotherapy
1
Prochlorperazine
1
Preoperative Exercise
1
Population Groups
1
Ondansetron
1
Olanzapine
1
Neurokinin-1 Receptor Antagonists
1
NK Cell Lectin-Like Receptor Subfamily B
1
Imagery, Psychotherapy
1
FloSeal Matrix
1
Ferric Oxide, Saccharated
1
Exercise
1
Enhanced Recovery After Surgery
1
Educational Status
1
Diagnostic Tests, Routine
1
Diagnostic Imaging
1
Dexamethasone
1
Cryotherapy
1
Counseling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gynecologic Cancer
×
Cisplatin
×
Gynecologic
×
Clear all
NCT03308604
2021-07-07
NANOCOL
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
Unknown
18 enrolled